Charles J. Collins Insider Trading $LMNX LUMINEX CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Charles J. Collins.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Charles J. Collins. Charles J. Collins is SR VP, R&D - US in LUMINEX CORP ($LMNX).
Charles J. Collins in LUMINEX CORP
Trading Symbol: LMNXIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Charles J. Collins: SR VP, R&D - US
Holdings: 49,503 shares
Current Value: $920,756
Latest Transaction: Mar 17 2021
$LMNX Market Capitalization: $799.33M
$LMNX Previous Close: $18.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Charles J. Collins in LUMINEX CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 17 2021 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Option Exercise | A | 23.09 | 64,868 | 1,497,802 | 64,868 | |
Mar 17 2021 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Grant | A | 32.76 | 14,652 | 480,000 | 49,503 | 34.9 K to 49.5 K (+42.04 %) |
Jul 20 2020 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Option Exercise | M | 18.04 | 13,343 | 240,708 | 33,542 | |
Jul 20 2020 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Option Exercise | M | 19.48 | 9,405 | 183,209 | 0 | |
Jul 20 2020 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Sell | S | 37.00 | 13,343 | 493,691 | 34,554 | 47.9 K to 34.6 K (-27.86 %) |
Jul 20 2020 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Buy | M | 18.04 | 13,343 | 240,708 | 47,897 | 34.6 K to 47.9 K (+38.61 %) |
Jul 20 2020 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Sell | S | 37.00 | 9,405 | 347,985 | 34,554 | 44 K to 34.6 K (-21.39 %) |
Jul 20 2020 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Buy | M | 19.48 | 9,405 | 183,209 | 43,959 | 34.6 K to 44 K (+27.22 %) |
Jul 17 2020 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Option Exercise | M | 15.93 | 37,252 | 593,424 | 0 | |
Jul 17 2020 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Sell | S | 34.50 | 37,252 | 1,285,298 | 34,554 | 71.8 K to 34.6 K (-51.88 %) |
Jul 17 2020 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Buy | M | 15.93 | 37,252 | 593,424 | 71,462 | 34.2 K to 71.5 K (+108.89 %) |
Jul 17 2020 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Option Exercise | M | 15.93 | 37,252 | 593,424 | 0 | |
Jul 17 2020 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Sell | S | 34.50 | 37,252 | 1,285,298 | 34,554 | 71.8 K to 34.6 K (-51.88 %) |
Jul 17 2020 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Buy | M | 15.93 | 37,252 | 593,424 | 71,462 | 34.2 K to 71.5 K (+108.89 %) |
Mar 13 2020 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Option Exercise | A | 24.43 | 18,888 | 461,434 | 18,888 | |
Mar 13 2020 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Grant | A | 23.09 | 8,661 | 199,982 | 34,210 | 25.5 K to 34.2 K (+33.90 %) |
Mar 13 2020 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Payment of Exercise | F | 23.09 | 878 | 20,273 | 25,549 | 26.4 K to 25.5 K (-3.32 %) |
Mar 13 2020 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Payment of Exercise | F | 27.11 | 776 | 21,037 | 26,427 | 27.2 K to 26.4 K (-2.85 %) |
Feb 21 2020 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Sell | S | 23.53 | 6,090 | 143,297 | 27,203 | 33.3 K to 27.2 K (-18.29 %) |
Mar 14 2019 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Option Exercise | A | 21.98 | 22,529 | 495,187 | 22,529 | |
Mar 14 2019 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Grant | A | 24.43 | 7,163 | 174,992 | 32,622 | 25.5 K to 32.6 K (+28.14 %) |
Mar 14 2019 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Payment of Exercise | F | 24.43 | 442 | 10,798 | 24,880 | 25.3 K to 24.9 K (-1.75 %) |
Mar 14 2019 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Payment of Exercise | F | 24.14 | 782 | 18,877 | 25,322 | 26.1 K to 25.3 K (-3.00 %) |
Jun 01 2018 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Option Exercise | M | 21.36 | 3,132 | 66,900 | 0 | |
Jun 01 2018 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Option Exercise | M | 17.24 | 5,973 | 102,975 | 0 | |
Jun 01 2018 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Sell | S | 27.75 | 6,451 | 179,015 | 26,104 | 32.6 K to 26.1 K (-19.82 %) |
Jun 01 2018 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Sell | S | 27.75 | 1,466 | 40,682 | 32,555 | 34 K to 32.6 K (-4.31 %) |
Jun 01 2018 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Sell | S | 27.75 | 3,132 | 86,913 | 34,021 | 37.2 K to 34 K (-8.43 %) |
Jun 01 2018 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Sell | S | 27.75 | 5,973 | 165,751 | 37,153 | 43.1 K to 37.2 K (-13.85 %) |
Jun 01 2018 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Buy | M | 21.36 | 3,132 | 66,900 | 43,126 | 40 K to 43.1 K (+7.83 %) |
Jun 01 2018 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Buy | M | 17.24 | 5,973 | 102,975 | 39,994 | 34 K to 40 K (+17.56 %) |
Mar 15 2018 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Grant | A | 21.98 | 7,279 | 159,992 | 34,021 | 26.7 K to 34 K (+27.22 %) |
Mar 15 2018 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Payment of Exercise | F | 21.98 | 1,057 | 23,233 | 26,742 | 27.8 K to 26.7 K (-3.80 %) |
Mar 15 2018 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Payment of Exercise | F | 21.73 | 782 | 16,993 | 27,799 | 28.6 K to 27.8 K (-2.74 %) |
Mar 12 2018 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Option Exercise | A | 18.04 | 46,885 | 845,805 | 46,885 | |
Mar 12 2018 | LMNX | LUMINEX CORP | Collins Charles J. | SR VP, R&D - US | Payment of Exercise | F | 21.06 | 275 | 5,792 | 28,581 | 28.9 K to 28.6 K (-0.95 %) |
Page: 1